Eli Lilly and (LLY)

NYSE: LLY · Real-Time Price · USD

794.79

-104.16 (-11.59%)

At close: May 01, 2025, 3:59 PM

Eli Lilly and Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.27B	2.82B	2.07B	3.82B	3.66B	2.34B	7.32B	6.54B	4.58B
Short-Term Investments	154.8M	109.1M	144.8M	90.1M	24.2M	101M	88.2M	1.5B	1.46B
Long-Term Investments	3.22B	3.05B	2.9B	3.21B	2.97B	1.96B	2.02B	5.68B	5.21B
Other Long-Term Assets	5.72B	4.99B	4.34B	4.08B	3.48B	2.34B	8.3B	2.87B	1.91B
Receivables	n/a	11.34B	8.56B	8.13B	6.93B	5.54B	5.78B	5.26B	4.77B
Inventory	n/a	5.77B	4.31B	3.89B	3.98B	3.19B	3.1B	4.46B	3.56B
Other Current Assets	111.4M	149.5M	7.3M	n/a	n/a	n/a	2.23B	n/a	n/a
Total Current Assets	32.74B	25.73B	18.03B	18.45B	17.46B	13.71B	20.55B	19.2B	15.1B
Property-Plant & Equipment	17.1B	12.91B	10.14B	8.99B	8.68B	8.4B	8B	8.83B	8.25B
Goodwill & Intangibles	11.94B	11.85B	11.28B	11.58B	11.22B	10.3B	2.43B	8.4B	8.33B
Total Long-Term Assets	45.98B	38.28B	31.46B	30.35B	29.17B	25.58B	23.36B	25.78B	23.7B
Total Assets	78.71B	64.01B	49.49B	48.81B	46.63B	39.29B	43.91B	44.98B	38.81B
Account Payables	n/a	2.6B	1.93B	1.67B	1.61B	1.41B	1.21B	1.41B	1.35B
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	6.9B	1.5B	1.54B	8.7M	1.52B	1.1B	3.71B	1.94B
Other Current Liabilities	28.38B	16.14B	12.17B	3.84B	9.3B	7.71B	3.69B	7.82B	6.61B
Total Current Liabilities	28.38B	27.29B	17.14B	15.05B	12.48B	11.78B	11.89B	14.54B	10.99B
Long-Term Debt	n/a	18.32B	14.74B	15.35B	16.59B	13.82B	9.2B	9.93B	8.37B
Other Long-Term Liabilities	36.07B	7.53B	6.75B	7.52B	9.64B	8.32B	10.6B	8.85B	5.37B
Total Long-Term Liabilities	36.07B	25.85B	21.58B	24.6B	28.33B	24.81B	21.11B	18.78B	13.74B
Total Liabilities	64.44B	53.14B	38.71B	39.65B	40.81B	36.59B	33B	33.31B	24.73B
Total Debt	33.64B	25.23B	16.24B	16.88B	16.6B	15.8B	10.3B	13.65B	10.31B
Common Stock	592.4M	593.6M	594.1M	596.3M	598.2M	598.8M	661M	687.9M	688.5M
Retained Earnings	n/a	10.31B	10.04B	8.96B	7.83B	4.92B	11.4B	13.89B	16.05B
Comprehensive Income	-4.32B	-4.33B	-6.86B	-7.36B	-9.51B	-9.54B	-8.74B	-8.73B	-8.29B
Shareholders Equity	14.19B	10.77B	10.65B	8.98B	5.64B	2.61B	9.83B	11.59B	14.01B
Total Investments	3.37B	3.16B	3.05B	3.3B	2.99B	2.06B	2.09B	7.18B	6.66B